The 8th STEPS HIV Cure Community-led Workshop will take place on Sunday October 23, 2022, from 10:15 to 12:15 (UK time) in Glasgow (Scotland, UK) at the SEC Armadillo, Carron 1 Room.
If you are interested in knowing more about HIV cure-related research in Europe from a community perspective, you are invited to apply to the 8th community meeting focused on HIV cure strategies, therapeutic vaccines and innovative approaches for a long-term remission of HIV infection. The meeting is organised by the European AIDS Treatment Group (EATG).
The STEPS workshops are led by EATG and are primarily of interest for the community of people living with HIV but aims to engage with a wide range of stakeholders including researchers, healthcare professionals, industry and any other person with an interest in the scientific research for long-term drug-free remission of HIV infection and the consequent implications for the community. The workshop will be held in English.
The meeting will cover the following topics:
The workshop was coordinated by Sean Hosein and will be chaired by Brian West.
Welcome & Introduction | Brian West EATG |
Overview of HIV cure/remission research with different approaches | Casper Rokx Erasmus University Medical Center and EHEG (Rotterdam, the Netherlands) |
Approaches to remission and European research in therapeutic vaccines | Jean-Daniel Lelievre CHU Henri Mondor |
Community perspective on cure/remission research | Simon Collins EATG / HIV i-Base Memory Sachikonye EATG / HIV i-Base |
Q&A Session | Moderator: Brian WestEATG |
Conclusion & Follow Up | Brian West EATG |
The workshop is open to everyone interested. You can just come to the meeting room on the planned date and time.
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.